Form 4 for WST West Pharmaceutical Services
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-18 · accession 0000105770-26-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-19 | 2026-02-18 | WST | Poussot Rodolphe Jean | SVP, Strategy, Corp. Dev | F - Tax | $248.26 | -27.81 | 307.40 | -8% | -$6,904 |
| D | 2026-02-19 | 2026-02-18 | WST | Poussot Rodolphe Jean | SVP, Strategy, Corp. Dev | M - OptEx | — | +82.30 | 335.21 | +33% | — |
| D | 2026-02-19 | 2026-02-18 | WST | Poussot Rodolphe Jean | SVP, Strategy, Corp. Dev | M - OptEx | $0.00 | -82.30 | 247.90 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | F | D | 27.81 | $248.26 | 307.40 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-18 | M | A | 82.30 | — | 335.21 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Rst. Stock Unit | 2026-02-18 | M | D | 82.30 | $0.00 | 247.90 | D | — · — to — | 82.30 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On February 18, 2025, the reporting person was granted 329 restricted stock units, vesting in four equal annual installments (plus dividend equivalents). |